Regulatory changes for generic ranitidine formulations are being sought by key participants in the global ranitidine market. The U.S. Food and Drug Administration (FDA) approved Aurobindo Pharma to market a generic version of ranitidine syrup in the U.S. in August 2010. Ranitidine syrup from Aurobindo Pharma is a synthetic form of Zantac syrup from GlaxoSmithKline. Granules India Limited obtained FDA authorization for Ranitidine HCL 150 mg tablets and 150 mg Cool Mint tablets in August 2018. (OTC). Sanofi-aventis’ 150 mg Zantac tablets are bioequivalent to this medication.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/2131
Browse Market Data Tables and 25 Figures spread through 145 Pages and in-depth TOC on “Global Ranitidine Market, , by Strength (300 mg, 75 mg, and 150 mg), by Form (Injection, Tablets, and Syrup), by Route of Administration (Intravenous and Oral), by Application (Zollinger-Ellison Syndrome, Stomach & Intestinal Ulcers, Esophagitis, and GERD (Gastroesophageal Reflux Disease)), and by Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies)- Global Forecast to 2026”
Moreover, key players’ increasing strategic collaboration and joint ventures to introduce innovative ranitidine-based products are likely to propel the ranitidine market forward. Captain Zantac, a new marketing campaign for Boehringer Ingelheim Consumer Health Care’s Zantac brand, was introduced in September 2013 by Boehringer Ingelheim GmbH. Captain Zantac is a new 360-degree brand equity campaign by Boehringer Ingelheim Consumer Health Care, which combines national commercials and a variety of additional promotional campaigns in print, internet, and retail. Strides Pharma Science Limited and Vivimed Labs inked a final agreement in May 2017 to form a 50:50 joint venture in the U.S. to commercialize ranitidine tablet 150 mg. Strides Shasun introduced Ranitidine Tablets USP, 150 mg in the United States in February 2018. Ranitidine Tablets USP, 75 mg were released on the US market in March 2018. Strides’ ranitidine portfolio would be bolstered by the new introduction.
Key Takeaways
Due to the increased incidence of digestive disorders globally, such as gastroesophageal reflux disease (GERD), intestinal and stomach ulcers, esophagitis, and Zollinger-Ellison syndrome, the global ranitidine market is anticipated to grow at a CAGR of 1.8 percent over the forecast period (2018-2026).
Ranitidine 150 mg pill accounted for the majority of the market share in 2017. A 150 mg dosage twice a day or a 300 mg dose at bedtime is usually administered for stomach or intestinal ulcers and GERD. The 150 mg tablet segment dominates the market, although the patient’s preference for 75 mg, 150 mg, or 300 mg medicine is determined by their clinical state.
Tablets have a large market share in the form sector, owing to its ease and mobility in daily life.
Oral administration accounted for a larger market share than intravenous administration, owing to the fact that intravenous administration needs a prescription from a healthcare practitioner. Orally, ranitidine can be taken as a tablet or a syrup.
In 2017, the intestinal and stomach ulcers category commanded the majority of market share. The most popular form of ulcer is a gastric or intestinal ulcer, which causes painful sores in the stomach lining and affects the stomach and small intestines.
In 2017, the retail pharmacy sector dominated the distribution platform. Retail pharmacies are an important avenue for distributing ranitidine to people suffering from digestive disorders.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/2131
Key companies contributing in the global ranitidine market are Strides Pharma Science Limited, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Sun Pharmaceutical Industries Limited, Merck KGaA, and Tocris Bioscience.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Strength
- Market Snippet, By Form
- Market Snippet, By Route of Administration
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Market Trends
- Epidemiology
- Approvals/Launches
- Mergers/ Acquisition
- Strategic Collaborations
- PEST Analysis
- Market Dynamics
- Global Ranitidine Market, By Strength, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- 75 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- 150 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- 300 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Ranitidine Market, By Form, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Syrup
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Ranitidine Market, By Route of Administration, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Ranitidine Market, By Application, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Intestinal & Stomach Ulcers
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Esophagitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Zollinger-Ellison Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Ranitidine Market, By Distribution Channel, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
- Introduction
- Global Ranitidine Market, By Region, 2016 – 2026 (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Region, 2017 – 2026
- North America
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Form, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Form, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Form, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Form, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Form, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Form, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Application, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837